Predictive Oncology Inc. (NASDAQ:POAI – Get Free Report)’s share price crossed above its 50 day moving average during trading on Monday. The stock has a 50 day moving average of $10.18 and traded as high as $12.50. Predictive Oncology shares last traded at $12.08, with a volume of 251,452 shares trading hands.
Predictive Oncology Price Performance
The company has a 50 day simple moving average of $10.29 and a 200-day simple moving average of $7.40. The stock has a market cap of $41.71 million, a P/E ratio of -0.91 and a beta of 1.35.
About Predictive Oncology
Predictive Oncology Inc (NASDAQ: POAI) is a biotechnology company focused on applying artificial intelligence and machine learning to oncology drug discovery and precision medicine. The company combines computational tools with biological data to help identify promising therapeutic candidates and predict how individual tumors may respond to specific treatments.
Its technology platform is built around a proprietary collection of tumor samples and associated clinical and drug-response information.
Recommended Stories
- Five stocks we like better than Predictive Oncology
- Skydance Just Became a Media Giant—With an $80 Billion Debt Load
- Could Velo3D Be the Next Defense Buyout Target?
- Penguin Solutions Is Soaring as AI Memory Demand Explodes
- Alphabet’s Chart Is Coiling—and the Fundamentals May Be Ready to Back It Up
Receive News & Ratings for Predictive Oncology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Predictive Oncology and related companies with MarketBeat.com's FREE daily email newsletter.
